John T Cavan's Net Worth

-$15.6 Thousand

Estimate Recalculated Mar 7, 2024 04:18PM EST

Who is John T Cavan?

John T Cavan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Hepion Pharmaceuticals, Inc., and Aegerion Pharmaceuticals, Inc..

SEC CIK

John T Cavan's CIK is 0001503738

Past Insider Trading and Trends

2017 was John T Cavan's most active year for acquiring shares with 3 total transactions. John T Cavan's most active month to acquire stocks was the month of June. 2018 saw John T Cavan paying a total of $8,640,000.00 for 109,861 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Hepion Pharmaceuticals, Inc. (HEPA) Snapshot price: $1.665

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 18
Form 4
+208.33%
10K
$2.00
$20,000.00
14.8K
Feb 18
Form 4
+1,500.00%
4.5K
$1.62
$7,290.00
4.8K
Nov 25
Form 4
—
0
—
—
0
Aug 19
Form 4
—
0
—
—
0
Apr 3
Form 4
—
0
—
—
0
Jul 24
Form 4
—
0
—
—
0
Jul 3
Form 4
+151.70%
101.22K
—
—
167.95K
Jan 3
Form 4
—
0
—
—
0
Jul 20
Form 4
+233.63%
46.73K
—
—
66.73K
Jul 6
Form 4
∞
20K
$0.65
$13,000.00
20K
Jun 20
Form 4
—
0
—
—
0
Aug 26
Form 3
—
0
—
—
0
No matching records found

Aegerion Pharmaceuticals, Inc. No price found

VP & Chief Accounting Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found